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INTRODUCTION:  Hemangiopericytoma  (HPC)  has  been  ﬁrst described  in 1942  by  Stout  as  a tumor  orig-
inating  from  the  capillary  surrounding  pericytes.  It is known  to occur  in  any  anatomical  site,  especially
the  extremities  and retroperitoneum.
PRESENTATION  OF CASE:  We  describe  a case  of a 24  year  old patient  presenting  with  lower  abdominal  pain
due  to a tumor  of the  greater  omentum,  the patient  was  treated  by  conventional  laparotomy  with  tumor
resection  and  the histological  evaluation  conﬁrmed  the  diagnosis  Hemangiopericytoma/Solitary  ﬁbrous
tumor  (HPC/SFT).  The  patient  has  regularly  followed-up  with  periodic  imaging  for the  last  4  years,  withesenchymal tumor
reater omentum
no recurrences.
DISCUSSION  AND  CONCLUSION:  According  to  our knowledge,  HPC  rarely  develops  in the  greater  omentum,
only  20 cases  were  described  in  the  literature.  Primary  surgical  resection  is  the  treatment  of choice.  There
is no beneﬁt  of radiation  or systemic  chemotherapy.  Angiogenic  inhibitors  represent  promising  systemic
therapeutic  concepts.
©  2016  The  Authors.  Published  by Elsevier  Ltd  on  behalf  of IJS  Publishing  Group  Ltd.  This  is an  open
access  article  under  the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).. Introduction
Hemangiopericytoma (HPC) is a tumor ﬁrst described in 1942 by
tout as a tumor originating from the capillary-surrounding peri-
ytes [1]. It is known to occur in any anatomical site, especially
he skeletal muscles, subcutaneous tissue of the lower limbs and
etroperitoneum [2]. HPC is most commonly prevalent amongst
ndividuals between 20 and 70 years, with the median age in the
0s [2]. HPC of the greater omentum is a rare condition, according to
ur knowledge; only 20 cases have been published till the current
ate (PubMed, National Library of Medicine, Bethesda MD,  USA).
his following article describes a case of HPC/SFT of the greater
mentum with discussion of the literature and the value of different
herapeutic options.
. Presentation of caseA 25-year-old male patient presenting with lower abdominal
ain was referred to our surgical department. The patient had no
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isceral and Transplant Surgery, Hoppe-Seyler-Str. 3, 72076 Tuebingen, Germany.
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ttp://dx.doi.org/10.1016/j.ijscr.2016.04.028
210-2612/© 2016 The Authors. Published by Elsevier Ltd on behalf of IJS Publishing G
reativecommons.org/licenses/by-nc-nd/4.0/).nausea or vomiting, no complaints of irregular bowel movements
or blood in stool. The patient reported no previous abdominal com-
plaints or interventions, apart from lower leg procedures as a result
of an injury seven years ago. Abdominal examination revealed a
slightly hyper-peristaltic bowel, with a soft consistency and a pal-
pable moveable mass in the upper abdomen, though no sign of
peritonitis. Ultrasound showed a solid intra-abdominal tumor lying
above the bladder. Abdominal CT-scan showed a hypervascularized
solid centrally inhomogeneous tumor measuring 5.7 × 8.3 × 6.8 cm
in the left lower quadrant lateral to the bladder, with an empha-
sized vascular supply originating from the left gastoepiploic vessels
(Fig. 1). Thorax CT-scan revealed no tumor. The patient was con-
sidered for surgical laparotomy and tumor resection, which was
carried out successfully.
Intraoperative ﬁndings showed a tumor within the greater
omentum, mainly supplied by the left gastroepiploic vessels (Fig. 2).
No peritoneal or organ metastasis were seen. The tumor was
removed en bloc with an omental root containing the supplying
vessels and was  sent for histological evaluation, which showed
alternating hypocellular and hypercellular areas and a focal myx-
oid change (Fig. 3). The round to spindle-shaped nuclei had little
cytoplasm and dispersed chromatin. The tumor was  rich in partly
hyalinised branching vessels. Mitotic counts reached 7 mitoses
per 10 high-power ﬁelds. In the immunohistochemical analysis,
roup Ltd. This is an open access article under the CC BY-NC-ND license (http://
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Fig. 1. Abdominal CT-scan showing a hypervascularized solid centrally inhomo-
geneous tumor measuring 5.7 × 8.3 × 6.8 cm in the left lower quadrant with an
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Fig. 2. Inraoperative image showing the tumor within the greater omentum, mainly
supplied by the left gastroepiploic vessels.mphasized vascular supply originating from the left gastoepiploic vessels.
he tumor showed a consistent positivity for CD34 and CD99
ith negativity for AE1/3, Desmin, CD31, CD117, DOG1 and S100.
roliferation rate assessed by MIB1 staining was 5%. These ﬁndings
onﬁrm hemangiopericytoma as a diagnosis and the resection mar-
in was free of tumor. The patient recovered with no complications
nd was discharged on the seventh postoperative day. The patient
as regularly followed-up with periodic imaging for the last 4 years,
ith no recurrences.
. Discussion and conclusion
Stout described several histological features of HPC in which
he perivascular cells had different appearences [1]. Stout origi-
ally acknowledged the fact that the term Haemangiopericytoma
as given in reference to Zimmermann’s pericytes, which became
uestioned due to the scientiﬁc basis of the assumption [3]. Fur-
hermore, studies have shown that only up to one third of HPCs
how speciﬁc ultrastructural [4,5] or immunhistochemical features
f pericytic origin [6,7]. As a consequence, the term solitary ﬁbrous
umor SFT is being frequently utilized to embrace all HPC-like
esions [8].
According to the literature, HPC/SFT has a favorable long-term
utcome after primary surgical resection [2,9]. HPC of the greater
mentum has shown to recur at local or distant sites in several cases
n the literature [10]. Enzinger and Smith suggested HPC malig-
ancy criteria to be large tumor size ( > 5 cm), increased mitotic
ate (≥4 mitotic ﬁgures/10HPF), high cellularity, presence of pleo-
orphic tumor cells and presence of haemorrhage and necrosis [2].
till, the behavior of lesions lacking the mentioned criteria cannot
e predicted [8]. Kaneko et al. concluded that a tumor size of more
han 20 cm is an unfavorable prognostic factor of greater omen-Fig. 3. Microscopic examination demonstrating numerous partly hyalinised
branching vessels (stag-horn appearance) in the high population of spindle-shaped
tumor cells. H&E, × 100.
tal HPC [10], though due to the limited number of cases on which
the conclusion was made as well as the different possible entities
of HPC/SFT, we believe that prognostic factors of omental HPC/SFT
are to be seen as those of other regions.Primary surgical resection is the treatment of choice, whenever
possible [9,11]. Literature reports showed no signiﬁcant beneﬁt of
radiation [12] or systemic chemotherapy [13,14], although a few
responses have been reported. Due to the rich vascular charac-
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eristics of these tumors, angiogentic inhibitors have emerged as
romising systemic therapeutic concepts [15].
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